A Drug Already Proven Safe in Humans Just Reduced Multiple Signs of Alzheimer's in Mice
A drug previously proven safe in humans, KCL-286, has shown the ability to reduce multiple signs of Alzheimer's disease in mice.
Velocity timeline
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Preclinical studies indicate that KCL-286, a drug originally intended for spinal cord injuries, may slow Alzheimer's disease in mice by targeting multiple disease pathways. The investigational drug specifically targets DNA damage as part of its mechanism.
Coverage from Technology Networks, Drug Target Review, Futurity, WebWire, and ScienceAlert emphasizes the drug's existing safety profile in humans and its effectiveness in reducing markers of the disease within animal models. Future developments depend on whether the results seen in mice translate to human treatments for Alzheimer's disease.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 24m ago.
Quick answers
What is the name of the drug?
The drug is identified as KCL-286.
What was the drug's original purpose?
The drug was developed for spinal cord injuries.
How does the drug work against Alzheimer's?
According to coverage, it targets DNA damage and multiple Alzheimer's pathways.
Coverage (5)
- Spinal Cord Injury Drug Shows Promise for Alzheimer’s Disease Technology Networks · 9h ago
- KCL-286 targets multiple Alzheimer’s pathways in preclinical study Drug Target Review · 9h ago
- New drug slows Alzheimer’s disease in mice Futurity · 9h ago
- Could an investigational drug that targets DNA damage help treat Alzheimer’s disease? WebWire · 9h ago
- A Drug Already Proven Safe in Humans Just Reduced Multiple Signs of Alzheimer's in Mice ScienceAlert · 9h ago broke it first
People, places & organizations
Topics
From around our network
- New Guidelines Issued for Alzheimer’s Disease Diagnosis and Detection newsdirectory3.com
Related trends
Scientists Discover a Sign of Dementia up to 15 Years Before Diagnosis
Scientists have identified indicators of dementia, including work performance shifts and blood biomarkers, that may appear up to 15 years before diagnosis.
Alcohol Alters Brain Flexibility Based on Hidden Dementia Markings
Alcohol consumption alters brain flexibility based on hidden dementia markings
Danny Glover, 79, reveals heartbreaking Alzheimer’s diagnosis: ‘Things are going to be different’
Actor Danny Glover, 79, has publicly announced his diagnosis of Alzheimer's disease.
Scientists may have finally found how Alzheimer's spreads through the brain
Researchers have identified the Arc protein as a key driver in the spread of toxic tau within the brain during Alzheimer's progression.
Alzheimer’s disease: Omega-3 DHA supplements may not reduce risk
New research is challenging the belief that Omega-3 DHA supplements can prevent Alzheimer's-related cognitive decline.
Sleep Habits Determine If Your Genes Accelerate Alzheimer’s
New research suggests sleep habits can influence how genetic risks for Alzheimer's disease manifest in the brain.